210 related articles for article (PubMed ID: 36432161)
21. An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS.
Otten JN; Hingorani GP; Hartley DP; Kragerud SD; Franklin RB
Drug Metab Lett; 2011 Jan; 5(1):17-24. PubMed ID: 21198441
[TBL] [Abstract][Full Text] [Related]
22. Simulation of phase I metabolism reactions of selected calcium channel blockers by human liver microsomes and photochemical methods with the use of Q-TOF LC/MS.
Gawlik M; Trawiński J; Skibiński R
J Pharm Biomed Anal; 2019 Oct; 175():112776. PubMed ID: 31351248
[TBL] [Abstract][Full Text] [Related]
23. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
[TBL] [Abstract][Full Text] [Related]
24. Development, optimization and implementation of a centralized metabolic soft spot assay.
Paiva AA; Klakouski C; Li S; Johnson BM; Shu YZ; Josephs J; Zvyaga T; Zamora I; Shou WZ
Bioanalysis; 2017 Apr; 9(7):541-552. PubMed ID: 28339283
[TBL] [Abstract][Full Text] [Related]
25. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples.
Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K
Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523
[TBL] [Abstract][Full Text] [Related]
26. Capsaicin metabolites and GSH-associated detoxification and biotransformation pathways in human liver microsomes revealed by LC-HRMS/MS with data-mining tools.
Qin L; Wang Y; Gong Y; Chen J; Xu B; Tang L; Guo L; Xie J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Dec; 1133():121843. PubMed ID: 31704446
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of vilazodone metabolites in rats and microsomes by ultrahigh-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.
Chavan BB; Kalariya PD; Tiwari S; Nimbalkar RD; Garg P; Srinivas R; Talluri MVNK
Rapid Commun Mass Spectrom; 2017 Dec; 31(23):1974-1984. PubMed ID: 28875544
[TBL] [Abstract][Full Text] [Related]
28. Prediction of biotransformation products of the fungicide fluopyram by electrochemistry coupled online to liquid chromatography-mass spectrometry and comparison with in vitro microsomal assays.
Mekonnen TF; Panne U; Koch M
Anal Bioanal Chem; 2018 Apr; 410(10):2607-2617. PubMed ID: 29455286
[TBL] [Abstract][Full Text] [Related]
29. Metabolite Identification of Isopropoxy Benzene Guanidine in Rat Liver Microsomes by Using UHPLC-Q-TOF-MS/MS.
Lu Y; Zhang W; Zhang Y; Wu S; Ma M; Peng X; Zeng Z; Zeng D
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108473
[TBL] [Abstract][Full Text] [Related]
30. LC-MS/MS method for the quantification of the anti-cancer agent infigratinib: Application for estimation of metabolic stability in human liver microsomes.
Mostafa GAE; Kadi AA; AlMasoud N; Attwa MW; Al-Shakliah NS; AlRabiah H
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122806. PubMed ID: 34325312
[TBL] [Abstract][Full Text] [Related]
31. Study of in-vitro metabolism of selected antibiotic drugs in human liver microsomes by liquid chromatography coupled with tandem mass spectrometry.
Szultka-Mlynska M; Buszewski B
Anal Bioanal Chem; 2016 Nov; 408(29):8273-8287. PubMed ID: 27704178
[TBL] [Abstract][Full Text] [Related]
32. Novel approach to performing metabolite identification in drug metabolism.
Nassar AE; Lee DY
J Chromatogr Sci; 2007 Mar; 45(3):113-9. PubMed ID: 17462124
[TBL] [Abstract][Full Text] [Related]
33. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
[TBL] [Abstract][Full Text] [Related]
34. UHPLC-Q-TOF-MS/MS-based screening and characterization of metabolites of cnidilin in human liver microsomes.
Yuan L; Zhang Y; Liao M; Liu Y; Wan C; Zhang L
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28431455
[TBL] [Abstract][Full Text] [Related]
35. An automated high throughput liquid chromatography-mass spectrometry process to assess the metabolic stability of drug candidates.
Drexler DM; Belcastro JV; Dickinson KE; Edinger KJ; Hnatyshyn SY; Josephs JL; Langish RA; McNaney CA; Santone KS; Shipkova PA; Tymiak AA; Zvyaga TA; Sanders M
Assay Drug Dev Technol; 2007 Apr; 5(2):247-64. PubMed ID: 17477833
[TBL] [Abstract][Full Text] [Related]
36. An efficient liquid chromatography-high resolution mass spectrometry approach for the optimization of the metabolic stability of therapeutic peptides.
Esposito S; Mele R; Ingenito R; Bianchi E; Bonelli F; Monteagudo E; Orsatti L
Anal Bioanal Chem; 2017 Apr; 409(10):2685-2696. PubMed ID: 28138743
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous determination of tolbutamide, omeprazole, midazolam and dextromethorphan in human plasma by LC-MS/MS--a high throughput approach to evaluate drug-drug interactions.
Zhang W; Han F; Guo P; Zhao H; Lin ZJ; Huang MQ; Bertelsen K; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 May; 878(15-16):1169-77. PubMed ID: 20378422
[TBL] [Abstract][Full Text] [Related]
38. Metabolic analysis of the illegal analogues of anti-obesity drugs using LC-Q-TOF-MS/MS.
Jeong D; Choe S; Lee S; Kim KM; Pyo J
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1163():122502. PubMed ID: 33412503
[TBL] [Abstract][Full Text] [Related]
39. Metabolite profiling of praziquantel and its analogs during the analysis of in vitro metabolic stability using information-dependent acquisition on a hybrid triple quadrupole linear ion trap mass spectrometer.
Huang J; Bathena SP; Alnouti Y
Drug Metab Pharmacokinet; 2010; 25(5):487-99. PubMed ID: 20877135
[TBL] [Abstract][Full Text] [Related]
40. In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS.
Kammerer B; Scheible H; Zurek G; Godejohann M; Zeller KP; Gleiter CH; Albrecht W; Laufer S
Xenobiotica; 2007 Mar; 37(3):280-97. PubMed ID: 17624026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
